- Home
- Lobbying firms
- Todd Strategy Group
Todd Strategy Group
Lobbying firm · Jul 2025 – Sep 2026
Todd Strategy Group earned $14.9M lobbying for 25 clients (Jul 2025 – Sep 2026). Biggest clients: Medical Countermeasures Coalition, Amgen, Eli Lilly And Company.
- Lobbying income
- $14.9M
- Clients
- 25
Clients
- Medical Countermeasures Coalition$600K
- Amgen$320K
- Eli Lilly And Company$320K
- Gilead Sciences, Inc.$320K
- Johnson & Johnson Services Inc$320K
- Astrazeneca Pharmaceuticals LP$320K
- Compass Pathways Inc.$320K
- Guardant Health Inc.$320K
- Pharmaceutical Research And Manufacturers Of America$280K
- The Coalition For 21ST Century Medicine$280K
- Illumina, Inc.$280K
- Action Now Initiative, LLC$240K
- Alkermes, Inc.$240K
- American Medical Association$240K
- Apollo Global Management$240K
- Genentech, Inc.$240K
- Genmab$240K
- Glaxosmithkline LLC$240K
- Novo Nordisk Inc.$240K
- Puerto Rico Department Of Health$240K
- Alnylam Pharmaceuticals, Inc.$240K
- Novartis$240K
- Pmi US Corporate Services Inc.$240K
- Delfi Diagnostics$240K
- Caredx, Inc.$240K
More
From Lobbying Disclosure Act reports.
Cite or embed this page
Capitol Receipts, “Todd Strategy Group: Lobbying Firm Clients & Income,” https://www.capitolreceipts.com/lobbying-firm/ftoddstrategygroup/todd-strategy-group (accessed 2026-10-13).